Jacques-Eric Gottenberg
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Smolen J, Landewé R, Bergstra S, Kerschbaumer A, Sepriano A, Aletaha D, Caporali R, Edwards C, Hyrich K, Pope J, de Souza S, Stamm T, Takeuchi T, Verschueren P, Winthrop K, Balsa A, Bathon J, Buch M, Burmester G, Buttgereit F, Cardiel M, Chatzidionysiou K, Codreanu C, Cutolo M, den Broeder A, El Aoufy K, Finckh A, Fonseca J, Gottenberg J, Haavardsholm E, Iagnocco A, Lauper K, Li Z, McInnes I, Mysler E, Nash P, Poór G, Ristic G, Rivellese F, Rubbert-Roth A, Schulze-Koops H, Stoilov N, Strangfeld A, van der Helm-van Mil A, van Duuren E, Vliet Vlieland T, Westhovens R, van der Heijde D. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis 2022
Nov 10, 2022EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Nov 10, 2022Ann Rheum Dis 2022
Smolen Josef S, Landewé Robert B M, Bergstra Sytske Anne, Kerschbaumer Andreas, Sepriano Alexandre, Aletaha Daniel, Caporali Roberto, Edwards Christopher John, Hyrich Kimme L, Pope Janet E, de Souza Savia, Stamm Tanja, Takeuchi Tsutomu, Verschueren Patrick, Winthrop Kevin, Balsa Alejandro, Bathon Joan M, Buch Maya H, Burmester Gerd R, Buttgereit Frank, Cardiel Mario Humberto, Chatzidionysiou Katerina, Codreanu Catalin, Cutolo Maurizio, den Broeder Alfons A, El Aoufy Khadija, Finckh Axel, Fonseca João Eurico, Gottenberg Jacques-Eric, Haavardsholm Espen A, Iagnocco Annamaria, Lauper Kim, Li Zhanguo, McInnes Iain B, Mysler Eduardo F, Nash Peter, Poór Gyula, Ristic Gorica G, Rivellese Felice, Rubbert-Roth Andrea, Schulze-Koops Hendrik, Stoilov Nikolay, Strangfeld Anja, van der Helm-van Mil Annette, van Duuren Elsa, Vliet Vlieland Theodora P M, Westhovens René, van der Heijde Désirée
Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
Rehberg M, Choy E, Rubbert-Roth A, Castañeda S, Schwarting A, Gottenberg J, Curtis J, Iglesias-Rodriguez M, van Hoogstraten H, Praestgaard A, Giegerich C, MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators. Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data. Rheumatol Ther 2021; 8:1921-1922.
Dec 1, 2021Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
Dec 1, 2021Rheumatol Ther 2021; 8:1921-1922
Rehberg Markus, Choy Ernest H S, Rubbert-Roth Andrea, Castañeda Santos, Schwarting Andreas, Gottenberg Jacques-Eric, Curtis Jeffrey R, Iglesias-Rodriguez Melitza, van Hoogstraten Hubert, Praestgaard Amy, Giegerich Clemens, MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators
Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
Rehberg M, Choy E, Rubbert-Roth A, Castañeda S, Schwarting A, Gottenberg J, Curtis J, Iglesias-Rodriguez M, van Hoogstraten H, Praestgaard A, Giegerich C, MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators. Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data. Rheumatol Ther 2021; 8:1661-1675.
Sep 14, 2021Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
Sep 14, 2021Rheumatol Ther 2021; 8:1661-1675
Rehberg Markus, Choy Ernest H S, Rubbert-Roth Andrea, Castañeda Santos, Schwarting Andreas, Gottenberg Jacques-Eric, Curtis Jeffrey R, Iglesias-Rodriguez Melitza, van Hoogstraten Hubert, Praestgaard Amy, Giegerich Clemens, MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
van der Heijde D, Mariette X, Li Z, Koloumas M, Huizinga T, Hetland M, Gottenberg J, Gossec L, Finckh A, Emery P, Müller-Ladner U, Mysler E, da Silva J, Westhovens R, Voshaar M, Takeuchi T, Strangfeld A, Saag K, Ruyssen-Witrand A, Rubbert-Roth A, Pope J, Poór G, van Eijk-Hustings Y, Edwards C, Cutolo M, de Wit M, van Vollenhoven R, Sepriano A, McInnes I, Kerschbaumer A, Dougados M, Burmester G, Bijlsma J, Landewé R, Aletaha D, Aringer M, Askling J, Codreanu C, De Cock D, Cardiel M, Caporali R, Buttgereit F, Buch M, den Broeder A, Boers M, Balsa A, Smolen J. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 2020; 79:685-699.
Jan 22, 2020EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Jan 22, 2020Ann Rheum Dis 2020; 79:685-699
van der Heijde Désirée, Mariette Xavier, Li Zhanguo, Koloumas Marios, Huizinga Tom W J, Hetland Merete Lund, Gottenberg Jacques-Eric, Gossec Laure, Finckh Axel, Emery Paul, Müller-Ladner Ulf, Mysler Eduardo F, da Silva Jose A P, Westhovens René, Voshaar Marieke, Takeuchi Tsutomu, Strangfeld Anja, Saag Kenneth G, Ruyssen-Witrand Adeline, Rubbert-Roth Andrea, Pope Janet E, Poór Gyula, van Eijk-Hustings Yvonne, Edwards Christopher John, Cutolo Maurizio, de Wit Maarten, van Vollenhoven Ronald F, Sepriano Alexandre, McInnes Iain B, Kerschbaumer Andreas, Dougados Maxime, Burmester Gerd R, Bijlsma Johannes W J, Landewé Robert B M, Aletaha Daniel, Aringer Martin, Askling John, Codreanu Catalin, De Cock Diederik, Cardiel Mario Humberto, Caporali Roberto, Buttgereit Frank, Buch Maya H, den Broeder Alfons A, Boers Maarten, Balsa Alejandro, Smolen Josef S